{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T00:41:38Z","timestamp":1788914498423,"version":"build-2803163510"},"reference-count":26,"publisher":"American Medical Association (AMA)","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Dermatol"],"published-print":{"date-parts":[[2022,10,1]]},"abstract":"Importance<\/jats:title>There is a knowledge gap about subcutaneous panniculitis-like T-cell lymphoma (SPTCL) owing to its rarity and diagnostic difficulty, resulting in an absence of well-documented large case series published to date.<\/jats:p><\/jats:sec>Objective<\/jats:title>To generate consensus knowledge by a joint multi-institutional review of SPTCL and related conditions.<\/jats:p><\/jats:sec>Design, Setting, and Participants<\/jats:title>This retrospective clinical and pathological review included cases initially diagnosed as SPTCL at 6 large US academic centers. All cases were reviewed by a group of pathologists, dermatologists, and oncologists with expertise in cutaneous lymphomas. Through a process of group consensus applying defined clinical and pathological diagnostic criteria, the cohort was classified as (1) SPTCL or (2) adipotropic lymphoproliferative disorder (ALPD) for similar cases with incomplete histopathological criteria for SPTCL designation.<\/jats:p><\/jats:sec>Exposures<\/jats:title>Cases of SPTCL diagnosed between 1998 and 2018.<\/jats:p><\/jats:sec>Main Outcomes and Measures<\/jats:title>The main outcome was disease presentation and evolution, including response to therapy, disease progression, and development of hemophagocytic lymphohistiocytosis.<\/jats:p><\/jats:sec>Results<\/jats:title>The cohort of 95 patients (median [range] age, 38 [2-81] years; female-to-male ratio, 2.7) included 75 cases of SPTCL and 20 cases of ALPD. The clinical presentation was similar for both groups with multiple (61 of 72 [85%]) or single (11 of 72 [15%]) tender nodules mostly involving extremities, occasionally resulting in lipoatrophy. Hemophagocytic lymphohistiocytosis (HLH) was only observed in SPTCL cases. With a mean follow-up of 56 months, 60 of 90 patients (67%) achieved complete remission with a median (range) of 3 (1-7) cumulative therapies. Relapse was common. None of the patients died of disease progression or HLH. Two patients with ALPD eventually progressed to SPTCL without associated systemic symptoms or HLH.<\/jats:p><\/jats:sec>Conclusions and Relevance<\/jats:title>In this case series of patients initially diagnosed as having SPTCL, results showed no evidence of systemic tumoral progression beyond the adipose tissue. The SPTCL experience in this study confirmed an indolent course and favorable response to a variety of treatments ranging from immune modulation to chemotherapy followed by hematopoietic stem cell transplantation. Morbidity was primarily associated with HLH.<\/jats:p><\/jats:sec>","DOI":"10.1001\/jamadermatol.2022.3347","type":"journal-article","created":{"date-parts":[[2022,8,24]],"date-time":"2022-08-24T15:32:56Z","timestamp":1661355176000},"page":"1167","source":"Crossref","is-referenced-by-count":33,"title":["Clinical and Pathological Characteristics and Outcomes Among Patients With Subcutaneous Panniculitis-like T-Cell Lymphoma and Related Adipotropic Lymphoproliferative Disorders"],"prefix":"10.1001","volume":"158","author":[{"given":"Joan","family":"Guitart","sequence":"first","affiliation":[{"name":"Department of Dermatology and Pathology, Northwestern University, Chicago, Illinois"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aaron R.","family":"Mangold","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Mayo Clinic Scottsdale, Scottsdale, Arizona"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Estela","family":"Martinez-Escala","sequence":"additional","affiliation":[{"name":"Department of Dermatology, University of Chicago Medical Center, Chicago, Illinois"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina J.","family":"Walker","sequence":"additional","affiliation":[{"name":"Department of Dermatology and Pathology, Northwestern University, Chicago, Illinois"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nneka I.","family":"Comfere","sequence":"additional","affiliation":[{"name":"Department of Dermatology and Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mellissa","family":"Pulitzer","sequence":"additional","affiliation":[{"name":"Medicine and Pathology, Memorial Sloan-Kettering Hospital, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kerri E.","family":"Rieger","sequence":"additional","affiliation":[{"name":"Department of Dermatology and Pathology, Stanford University, Palo Alto, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos A.","family":"Torres-Cabala","sequence":"additional","affiliation":[{"name":"Department of Dermatology and Pathology, University of Texas MD Anderson Cancer Center, Houston"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura B.","family":"Pincus","sequence":"additional","affiliation":[{"name":"Department of Dermatology, University of California, San Francisco"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erica S.","family":"Kumar","sequence":"additional","affiliation":[{"name":"Medicine and Pathology, Memorial Sloan-Kettering Hospital, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erica Bo Kyung","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Dermatology and Pathology, Stanford University, Palo Alto, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine E.","family":"Park","sequence":"additional","affiliation":[{"name":"Department of Dermatology and Pathology, University of Texas MD Anderson Cancer Center, Houston"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria L.","family":"Espinosa","sequence":"additional","affiliation":[{"name":"Department of Dermatology and Pathology, Northwestern University, Chicago, Illinois"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madeleine","family":"Duvic","sequence":"additional","affiliation":[{"name":"Department of Dermatology and Pathology, University of Texas MD Anderson Cancer Center, Houston"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youn H.","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Dermatology and Pathology, Stanford University, Palo Alto, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven","family":"Horwitz","sequence":"additional","affiliation":[{"name":"Medicine and Pathology, Memorial Sloan-Kettering Hospital, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"1","key":"doi220044r1","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1097\/00000478-199101000-00002","article-title":"T-cell lymphoma involving subcutaneous tissue: a clinicopathologic entity commonly associated with hemophagocytic syndrome.","volume":"15","author":"Gonzalez","year":"1991","journal-title":"Am J Surg Pathol"},{"issue":"2","key":"doi220044r3","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1182\/blood-2007-04-087288","article-title":"Subcutaneous panniculitis-like T-cell lymphoma: definition, classification, and prognostic factors: an EORTC Cutaneous Lymphoma Group study of 83 cases.","volume":"111","author":"Willemze","year":"2008","journal-title":"Blood"},{"issue":"6","key":"doi220044r4","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1097\/DAD.0b013e3181a84f32","article-title":"Subcutaneous panniculitis-like T-cell lymphoma with overlapping clinicopathologic features of lupus erythematosus: coexistence of 2 entities?","volume":"31","author":"Pincus","year":"2009","journal-title":"Am J Dermatopathol"},{"issue":"9","key":"doi220044r5","doi-asserted-by":"publisher","first-page":"2130","DOI":"10.1080\/10428194.2021.1901098","article-title":"Subcutaneous panniculitis-like T-cell lymphoma, lupus erythematosus profundus, and overlapping cases: molecular characterization through the study of 208 genes.","volume":"62","author":"Machan","year":"2021","journal-title":"Leuk Lymphoma"},{"issue":"12","key":"doi220044r6","doi-asserted-by":"publisher","first-page":"1650","DOI":"10.1038\/s41588-018-0251-4","article-title":"Germline HAVCR2 mutations altering TIM-3 characterize subcutaneous panniculitis-like T cell lymphomas with hemophagocytic lymphohistiocytic syndrome.","volume":"50","author":"Gayden","year":"2018","journal-title":"Nat Genet"},{"issue":"9","key":"doi220044r8","doi-asserted-by":"publisher","first-page":"2613","DOI":"10.1002\/art.38690","article-title":"Development and validation of the HScore, a score for the diagnosis of reactive hemophagocytic syndrome.","volume":"66","author":"Fardet","year":"2014","journal-title":"Arthritis Rheumatol"},{"issue":"2","key":"doi220044r9","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1002\/(ISSN)1545-5017","article-title":"HLH-2004: diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis.","volume":"48","author":"Henter","year":"2007","journal-title":"Pediatr Blood Cancer"},{"issue":"9","key":"doi220044r10","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.5858\/arpa.2013-0253-CR","article-title":"Lupus profundus (panniculitis): a potential mimic of subcutaneous panniculitis-like T-cell lymphoma.","volume":"137","author":"Arps","year":"2013","journal-title":"Arch Pathol Lab Med"},{"issue":"10","key":"doi220044r11","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1111\/cup.2008.35.issue-10","article-title":"Atypical lymphocytic lobular panniculitis: a clonal subcutaneous T-cell dyscrasia.","volume":"35","author":"Magro","year":"2008","journal-title":"J Cutan Pathol"},{"issue":"6","key":"doi220044r12","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1111\/his.2019.74.issue-6","article-title":"Utility of CD123 immunohistochemistry in differentiating lupus erythematosus from cutaneous T cell lymphoma.","volume":"74","author":"Chen","year":"2019","journal-title":"Histopathology"},{"issue":"2","key":"doi220044r13","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1097\/PAS.0000000000000307","article-title":"Lobular panniculitic infiltrates with overlapping histopathologic features of lupus panniculitis (lupus profundus) and subcutaneous T-cell lymphoma: a conceptual and practical dilemma.","volume":"39","author":"Bosisio","year":"2015","journal-title":"Am J Surg Pathol"},{"issue":"4","key":"doi220044r14","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1111\/(ISSN)1529-8019","article-title":"Subcutaneous lymphoma and related conditions.","volume":"23","author":"Guitart","year":"2010","journal-title":"Dermatol Ther"},{"issue":"6","key":"doi220044r15","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1038\/modpathol.2013.191","article-title":"Bone marrow involvement by subcutaneous panniculitis-like T-cell lymphoma: a report of three cases.","volume":"27","author":"Gao","year":"2014","journal-title":"Mod Pathol"},{"issue":"6","key":"doi220044r16","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.v67.6","article-title":"TIM-3 deficiency presenting with two clonally unrelated episodes of mesenteric and subcutaneous panniculitis-like T-cell lymphoma and hemophagocytic lymphohistiocytosis.","volume":"67","author":"Wegehaupt","year":"2020","journal-title":"Pediatr Blood Cancer"},{"key":"doi220044r17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/09546634.2020.1809624","article-title":"Subcutaneous panniculitis-like T-cell lymphoma (SPTCL) with probable mesentery involvement with associated hemophagocytic syndrome (HPS)\u2014how to treat it?","author":"Giza","year":"2022","journal-title":"J Dermatolog Treat"},{"issue":"3","key":"doi220044r18","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1111\/bjh.2018.181.issue-3","article-title":"Recurrent mutations in epigenetic modifiers and the PI3K\/AKT\/mTOR pathway in subcutaneous panniculitis-like T-cell lymphoma.","volume":"181","author":"Li","year":"2018","journal-title":"Br J Haematol"},{"issue":"4","key":"doi220044r19","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1182\/bloodadvances.2018028340","article-title":"Frequent germline mutations of HAVCR2 in sporadic subcutaneous panniculitis-like T-cell lymphoma.","volume":"3","author":"Polprasert","year":"2019","journal-title":"Blood Adv"},{"issue":"13","key":"doi220044r20","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1182\/blood.2019003811","article-title":"HAVCR2 mutations are associated with severe hemophagocytic syndrome in subcutaneous panniculitis-like T-cell lymphoma.","volume":"135","author":"Sonigo","year":"2020","journal-title":"Blood"},{"key":"doi220044r21","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s40842-019-0076-9","article-title":"Diagnosis of acquired generalized lipodystrophy in a single patient with T-cell lymphoma and no exposure to metreleptin.","volume":"5","author":"Esfandiari","year":"2019","journal-title":"Clin Diabetes Endocrinol"},{"issue":"4","key":"doi220044r22","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1097\/QAI.0000000000000001","article-title":"CD8 T-cell activation is associated with lipodystrophy and visceral fat accumulation in antiretroviral therapy-treated virologically suppressed HIV-infected patients.","volume":"64","author":"Guaraldi","year":"2013","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"3","key":"doi220044r23","doi-asserted-by":"publisher","first-page":"358","DOI":"10.2340\/00015555-2543","article-title":"Subcutaneous panniculitis-like T-cell lymphoma: immunosuppressive drugs induce better response than polychemotherapy.","volume":"97","author":"Michonneau","year":"2017","journal-title":"Acta Derm Venereol"},{"issue":"5","key":"doi220044r24","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1016\/j.jaad.2018.05.1243","article-title":"Subcutaneous panniculitis-like T-cell lymphoma: clinical features, therapeutic approach, and outcome in a case series of 16 patients.","volume":"79","author":"L\u00f3pez-Lerma","year":"2018","journal-title":"J Am Acad Dermatol"},{"issue":"12","key":"doi220044r25","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1016\/j.jdcr.2020.09.018","article-title":"Complete response to romidepsin as monotherapy in treatment-resistant subcutaneous panniculitis-like T-cell lymphoma.","volume":"6","author":"Jothishankar","year":"2020","journal-title":"JAAD Case Rep"},{"issue":"2","key":"doi220044r26","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1016\/j.jaad.2019.07.021","article-title":"Pralatrexate for refractory or recurrent subcutaneous panniculitis-like T-cell lymphoma with hemophagocytic syndrome.","volume":"82","author":"Ware","year":"2020","journal-title":"J Am Acad Dermatol"},{"key":"doi220044r2","volume-title":"Pathology and Genetics: Tumours of Haematopoietic and Lymphoid Tissues (World Health Organization Classification of Tumours)","author":"Jaffe","year":"2003"},{"key":"doi220044r7","unstructured":"National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines): primary cutaneous lymphomas. Version 2.2021. Accessed July 25, 2022. https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/primary_cutaneous.pdf"}],"container-title":["JAMA Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamadermatology\/articlepdf\/2795309\/jamadermatology_guitart_2022_oi_220044_1666117416.37488.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,19]],"date-time":"2022-10-19T15:09:48Z","timestamp":1666192188000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamadermatology\/fullarticle\/2795309"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,1]]},"references-count":26,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2022,10,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamadermatol.2022.3347","relation":{},"ISSN":["2168-6068"],"issn-type":[{"value":"2168-6068","type":"print"}],"subject":[],"published":{"date-parts":[[2022,10,1]]}}}